Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boehringer ingelheim
5
×
eli lilly
indiana blog main
indiana top stories
5
×
life sciences
national blog main
5
×
boston blog main
boston top stories
clinical trials
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
merck
moderna
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
abbvie
alzheimer's disease
deals
hepatitis b
What
bio
companies
roundup
week
debut
drug
life
moves
science
abandoning
acquisitions
ago
approval
arena’s
baggage
bid
biggest
black
boehringer
bounty
build
buy
ceo
cig
comeback
company’s
continue
corner
cuts
daniel
deal
deals
delivered
development
diabetes
diamond
diamond’s
dicerna
dyne’s
eli
Language
unset
Current search:
biotech
×
" national blog main "
×
" indiana top stories "
×
" boehringer ingelheim "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
